Image

Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients

Recruiting
25 years of age
Both
Phase N/A

Powered by AI

Overview

A 510k approved dental device for subjects requiring single or multiple tooth replacement with implants where immediate restoration/loading is preferred.

Description

The rationale for this study is to provide scientific data on the clinical performance and patient reported outcomes of the PrimeTaper EV implant when utilizing non-guided vs guided surgical technique. The PrimeTaper EV implant has the OsseoSpeed surface, which is especially indicated for use in soft bone applications where implants with other surface treatments may be less effective.

The main interests of this study are to assess the survival and the success rates of the implants supporting maxillary or mandibular fixed single or 2-fixture restorations after 1, 2, 3, 4 and 5 years in function

Eligibility

Inclusion Criteria:

  1. Subject ≥25 years.
  2. Subject has signed and dated the informed consent form prior to any study procedures.
  3. History of either a healed edentulous area or single or multiple teeth requiring extraction and in need of a single or fixed bridge prosthetic restoration and where immediate restoration/loading is preferred.
  4. Opposing jaw in the treatment area meets any of the following stable occlusal
    conditions

Complete denture Partial removable denture Fixed bridges and/or crowns Natural dentition

Exclusion Criteria:

        Any of the following is regarded as a criterion for exclusion from the study (all criteria
        apply at study inclusion, but criteria numbered 1-4 also apply during the entire study
        period):
          1. Unlikely to be able to comply with study procedures, according to the Investigator's
             judgment.
          2. Subject is not willing to participate in the study or not able to understand the
             content of the study.
          3. Involved in the planning and conduct of the study.
          4. Unable or unwilling to return for follow-up visits for a period of 5 years.
          5. Has an uncontrolled pathological process in the oral cavity (e.g. untreated
             periodontal disease, uncontrolled caries, severe malocclusion, etc.).
          6. Known or suspected current malignancy.
          7. History of radiation therapy in the head and neck region.
          8. History of chemotherapy within 5 years prior to surgery.
          9. Systemic or local disease or condition that could compromise post-operative healing
             and/or osseointegration (e.g., uncontrolled diabetes mellitus as reported by the
             subject).
         10. Use of systemic corticosteroids, IV bisphosphonates or any other medication that could
             compromise post-operative healing and/or osseointegration.
         11. Current alcohol and/or drug abuse.
         12. Smoking more than 10 cigarettes of any type per day.
         13. Current need for major bone grafting and/or augmentation in the planned implant area
             (esthetic augmentation and minor facial grafting are allowed).
         14. Known pregnancy, or plans to become pregnant during the study period of 5 years
         15. Participation in another clinical study within the previous 6 months that may
             interfere with the present study.
             Post-surgical Exclusion criteria
         16. Insufficient primary stability, as judged by the investigator, of the implant(s).
         17. Severe non-compliance to CIP as judged by the Investigator and/or Dentsply Sirona
             Implants.

Study details

Partially Edentulous Maxilla or Mandible

NCT05264545

McGuire Institute

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.